Maximus misses Q4 estimates, guides fiscal 2027 above views
Maximus Inc. (MMS) reported Q4 adjusted EPS of $2.11, missing estimates by $0.20, with revenue at $1.3B, down 1.3% YoY. For fiscal 2027, MMS guided revenue to $5.45B-$5.65B, above consensus, but EPS guidance was below expectations. The company attributed revenue decline to lower disaster support and temporary program volumes. MMS completed the acquisition of Agile Defense, expecting it to contribute to fiscal 2027 revenue.
How this was made
The 30-second read
Why it matters
The key trading variable is the fiscal 2027 adjusted EPS guidance midpoint ($7.75) falling below consensus, despite revenue guidance exceeding consensus. The article also ties the difference to the removal of an estimated $1.05 per share incentive benefit, and it frames growth via the Agile Defense acquisition completed on Nov 18, 2026.
Market read
This is a direct earnings and guidance update with specific Q4 misses and fiscal 2027 EPS and revenue guidance ranges, creating an actionable repricing window for MMS.
What to watch
The guidance excludes VA Medical Disability Examination incentive benefits; traders may need to separate normalized earnings from one-time incentive effects when assessing longer-run margin trajectory.
Background
Maximus reported Q4 results below Wall Street expectations and issued fiscal 2027 guidance, while noting fiscal 2027 excludes VA Medical Disability Examination program incentive benefits that boosted fiscal 2026.
Ticker impact
Maximus (MMS) missed Q4 EPS and revenue estimates and guided fiscal 2027 revenue above consensus but adjusted EPS below consensus.
Likely downside bias as the market reprices fiscal 2027 earnings power after the EPS guide and incentive exclusion.
The article provides fresh, company-specific Q4 results and fiscal 2027 guidance ranges, including the explicit $1.05 per share incentive exclusion that helps explain the EPS guide shortfall.
Market effects
Could modestly affect sentiment for government services and healthcare-adjacent outsourcing peers by reinforcing execution and incentive-dependence themes.
Primarily US large-cap services sentiment; limited direct regional spillover beyond government-services investors.
Low global relevance, as the catalyst is company-specific earnings and US fiscal guidance.
Counterpoint
Investors may look past the adjusted EPS miss by emphasizing fiscal 2027 revenue midpoint above consensus and expected Agile Defense contribution plus free cash flow guidance.
Key entities
- companyMaximus Inc.
US government services and healthcare-related contractor that reported Q4 results and issued fiscal 2027 guidance.
- acquired_companyAgile Defense
Acquisition completed Nov 18, 2026, expected to contribute about ten months of revenue in fiscal 2027.
- programVA Medical Disability Examination program incentives
Incentive benefits included in fiscal 2026 results but excluded from fiscal 2027 guidance.


